 Nitta Gelatin India Ltd Q2 FY2025-26 consolidated profit lower at Rs. 18.42 crores
Nitta Gelatin India Ltd Q2 FY2025-26 consolidated profit lower at Rs. 18.42 crores Wheels India Ltd consolidated Q2 FY26 net profit up at Rs. 30.99 crores
Wheels India Ltd consolidated Q2 FY26 net profit up at Rs. 30.99 crores Kalpataru Projects International Ltd posts rise in Q2FY26 consolidated PAT to Rs. 240.05 crores
Kalpataru Projects International Ltd posts rise in Q2FY26 consolidated PAT to Rs. 240.05 crores Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores
Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26
GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26 
              Bombay Stock Exchange has announced that effective from Friday, July 11, 2008; the equity shares of Lotus Eye Care Hospital Limited (Scrip Code: 532998) shall be listed and admitted to dealings on the Exchange in the list of ‘B’ Group of Securities.
The equity shares of Lotus Eye Care Hospital Limited (Symbol: LOTUSEYE) shall be listed and admitted to dealings on the National Stock Exchange w.e.f. July 11, 2008. Trading shall be in the Normal Market segment – Compulsory Demat (Rolling Settlement) for all investors.
The ISIN Code of the company is INE947I01017.
The company issued shares in the recently concluded IPO at a price of Rs. 38/- per share (Face Value of Rs.10/- and premium of Rs. 28/-)
S.K.D.C Consultants Limited is the Registrar to the issue.